The Valley Desk

NCT06765109 · Interventional trial

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Overall registry status Recruiting

Phase 3

Conditions Anaplastic Lymphoma Kinase-positive, Non-small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov